MT1 melatonin receptor expression in Warthin's tumor.
We contribute the first immunohistochemical study of MT1 melatonin receptor in Warthin's tumor and normal parotid gland. All 14 Warthin's tumors studied showed intense cytoplasmic positivity for MT1 receptor in all cylindrical epithelial cells lining spaces and a less intense positivity in basal cells. The lymphoid component accompanying the tumor was always negative for MT1 receptor. The parotid structure surrounding the tumor showed intense cytoplasmic positivity in all cells lining excretory ducts (lobar and lobulillar), with a lesser and focal positivity in cells of the acinar component. The biological activity of MT1 receptor in epithelial cells lining parotid excretory ducts may resemble its activity in Warthin's tumor cells. Hence, we propose Warthin's tumor as a useful positive control in immunohistochemical studies of MT1 melatonin receptor.
Department of Pathology, San Cecilio University Hospital, Granada, Spain.
Jose
J
Aneiros-Fernandez
Salvador
S
Arias-Santiago
Borja
B
Arias-Santiago
Maria
M
Herrero-Fernández
V
V
Carriel
Jose
J
Aneiros-Cachaza
Antonio
A
López-Valverde
Antonio
A
Cutando-Soriano
D000235:Adenolymphoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D000328:Adult; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D010306:Parotid Gland / Q000378:metabolism / Q000473:pathology; D044122:Receptor, Melatonin, MT1 / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism
D044122:Receptor, Melatonin, MT1